Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 590 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Studying The Effect Of Levocarnitine In Protecting The Liver From Chemotherapy For Leukemia Or Lymphoma

    Rochester, MN

  2. Pre-myeloid Cancer And Bone Marrow Failure Clinic Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Study Of GI-102 And PD-1 In Glioblastoma

    Rochester, MN

  4. Accelerated Vs Standard BEP Chemotherapy For Patients With Intermediate And Poor-risk Metastatic Germ Cell Tumours

    Rochester, MN

  5. A Study To Evaluate The Safety And Effectiveness Of Lisocatagene Maraleucel In Patients

    Jacksonville, FL, Rochester, MN

  6. INCB161734 For Advanced Or Metastatic Solid Tumors With KRAS G12D Mutation

    Scottsdale/Phoenix, AZ

  7. FOG-001 In Locally Advanced Or Metastatic Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Phase 1 Study To Investigate TCRTs KRAS Mutation In Unresectable, Advanced, And/or Metastatic Solid Tumors

    Jacksonville, FL

  9. 5-strain Probiotic Formulation In Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor To Prevent Bone Loss

    Jacksonville, FL

  10. A Study To Compare Linvoseltamab And Daratumumab Treatment In High-Risk Smoldering Multiple Myeloma (HR-SMM)

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer